ep 24. alzheimer’s disease and how we can (sorta) treat it
June is Alzheimer’s Disease Awareness Month! In this episode of the podcast, sam-splains Alzheimer’s disease in a societal and neurobiological context. We also talk about aducanumab - the drug that was FDA approved for Alzheimer’s Disease last year!
Sources:
DeTure, M.A. and D.W. Dickson, The neuropathological diagnosis of Alzheimer’s disease (2019). Molecular Neurodegeneration. Link: https://molecularneurodegeneration.biomedcentral.com/articles/10.1186/s13024-019-0333-5
Budd Haeberlein, S. et al., Two Randomized Phase 3 Studies of Aducanumab in Early Alzheimer’s Disease. (2022). J Prev Alz Dis. Link: https://link.springer.com/article/10.14283/jpad.2022.30#Sec1
Follow the show:
Ask a question:
